MARQIBO Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Marqibo, and when can generic versions of Marqibo launch?
Marqibo is a drug marketed by Acrotech and is included in one NDA.
The generic ingredient in MARQIBO is vincristine sulfate. There are thirteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the vincristine sulfate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for MARQIBO?
- What are the global sales for MARQIBO?
- What is Average Wholesale Price for MARQIBO?
Summary for MARQIBO
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Prices: | Drug price information for MARQIBO |
| What excipients (inactive ingredients) are in MARQIBO? | MARQIBO excipients list |
| DailyMed Link: | MARQIBO at DailyMed |
US Patents and Regulatory Information for MARQIBO
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Acrotech | MARQIBO KIT | vincristine sulfate | INJECTABLE, LIPOSOMAL;INTRAVENOUS | 202497-001 | Aug 9, 2012 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |


